Partnering & Collaborations

Lindis Biotech

Partnering | In a team, you do better

We welcome license or co-develop opportunities for our proprietary Triomab® antibody platform. We bring our partners comprehensive expertise in bio-pharmaceutical production as well as clinical development know-how in Triomab® antibodies.

Based on the nature of immune cell engaging therapies, Lindis Biotech’s pipeline products are also open to combination therapy collaborations of different types.

Contact us

License or co-develop opportunities are welcome!

Linton Pharm
www.lintonpharm.com
LintonPharm is our strategic partner in Guangzhou, China for the development of Triomab® and Fleximab® antibodies in Asia.

Trion Research
www.trionresearch.com
Trion Research is our research partner in Munich, Germany for discovery and development of new drug candidates.

University Hospital Leipzig
www.uniklinikum-leipzig.de
Institute for transfusion medicine, Dr. med. Raymund Buhmann.

The collaboration with the University Hospital in Leipzig, Germany aims at the development of Triomab® – armed immune effector cells for the treatment of hematological and oncological neoplasia.

Helmholtz-Zentrum München
www.helmholtz-muenchen.de
German research centre for environmental health

  • Prof. Dr. med. Ralph Mocikat: Leiter der Eigenständigen Forschungseinheit Translationale Molekulare Immunologie
  • Prof. Dr. Reinhard Zeidler: Abteilung Genvektoren. Deutsches Zentrum für Infektionsforschung

With the German research centre for environmental health we collaborate in diverse translational research projects.

Charité Berlin
www.charite.de

  • Department of Pediatrics, Division of Oncology and Hematology (PD Dr. med. Annette Künkele)

Together with our partner we promote the non-clinical development of GD2-specific Triomab® antibodies.

Location

Lindis Biotech is located in the Innovation and Start-up Center for Biotechnology (IZB) in Martinsried, Munich – one of the most vibrant biotech hot spots in Europe.